UTICA, N.Y., Oct. 4 /PRNewswire/ -- ConMed Corporation (Nasdaq: CNMD)
today announced that Joseph Corasanti, President and Chief Operating Officer,
and Robert Shallish, Chief Financial Officer, will present at the UBS Warburg
Global Life Sciences Conference on October 8 at 1:00 p.m. (Eastern). This
conference will be held at The Pierre Hotel in New York City.
Listen-only telephone conference lines will be available for public access
to hear the conference presentations. Investors may access the presentation
at the following numbers:
Live: 1-800-500-0177 (domestic) and
1-719-457-2679 (international)
Recorded: 1-800-759-8603 (domestic) and
1-402-220-8537 (international)
The Company's presentation will include a description of the Company's
business and historical financial results. Forward-looking information and
the Company's expectations on a prospective basis may also be discussed during
the presentation.
CONMED is a medical technology company specializing in instruments and
implants for arthroscopic sports medicine and powered surgical instruments,
such as drills and saws, for orthopedic, ENT and neuro-surgery. The Company
is also a leading developer, manufacturer and supplier of advanced medical
devices, including RF electrosurgery systems used in all types of surgery, ECG
electrodes for heart monitoring and minimally invasive surgical devices.
Headquartered in Utica, New York, the Company's 2,400 employees distribute its
products worldwide from eight manufacturing locations.
SOURCE ConMed Corporation
 back to top
Related links:
http://www.conmed.com
Company News On-Call:
http://www.prnewswire.com/comp/201850.html
CONTACT:
Robert Shallish, Chief Financial Officer,
ConMed Corporation, +1-315-624-3206; or Investors - Theresa Vogt
or Lanie Fladell, or Media - Dan Budwick, all of Morgen-Walke
Associates, +1-212-850-5600, for ConMed Corporation
|
